Related Experiment Video
Updated: Sep 27, 2026

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
Organ specific acute toxicity of the carcinogen trans-4-acetylaminostilbene is not correlated with macromolecular
Abstract:
trans-4-Acetylaminostilbene (trans-AAS) is acutely toxic in rats and lesions are produced specifically in the glandular stomach. Toxicity is slightly increased by pretreating the animals with phenobarbital (PB) and is completely prevented by pretreatment with methylcholanthrene (MC). The prostaglandin inhibitors, indomethacin and acetyl salicylic acid, do not reduce toxicity. The high efficiency of MC suggested that toxicity is caused by reactive metabolites. trans-[3H]-AAS was administered orally to untreated and to PB- or MC-pretreated female Wistar rats and target doses in different tissues were measured by means of covalent binding to proteins, RNA and DNA. Macromolecular binding in the target tissue of poisoned animals was significantly lower than in liver and kidney and comparable to other non-target tissues. Pretreatment with MC lowered macromolecular binding in all extrahepatic tissues but not in liver. These findings are not in line with tissue specific metabolic activation. The only unique property of the target tissue, glandular stomach, that we observed was a particular affinity for the systemically available parent compound. In the early phase of poisoning, tissue concentrations were exceedingly high and the stomach function was impaired.
Insights
trans-4-Acetylaminostilbene (trans-AAS) causes acute stomach toxicity in rats. This toxicity is not due to reactive metabolites but rather the parent compound accumulating in the stomach.
Area of Science:
- Toxicology
- Pharmacology
- Gastroenterology
Background:
- trans-4-Acetylaminostilbene (trans-AAS) is known to cause acute toxicity in rats, specifically targeting the glandular stomach.
- Previous studies indicated that methylcholanthrene (MC) pretreatment prevents this toxicity, suggesting a role for reactive metabolites.
Purpose of the Study:
- To investigate the mechanism of trans-4-Acetylaminostilbene (trans-AAS) induced glandular stomach toxicity.
- To determine if toxicity is mediated by reactive metabolites or the parent compound.
Main Methods:
- Oral administration of trans-[3H]-AAS to Wistar rats under different pretreatment conditions (phenobarbital, methylcholanthrene).
- Measurement of covalent binding of trans-AAS to macromolecules (proteins, RNA, DNA) in various tissues.
- Assessment of tissue concentrations and stomach function.
Main Results:
- Macromolecular binding of trans-AAS was lower in the target glandular stomach compared to liver and kidney.
- Methylcholanthrene pretreatment reduced binding in extrahepatic tissues but not in the liver.
- The glandular stomach showed a high affinity for the parent trans-AAS compound, with high concentrations observed early in poisoning.
Conclusions:
- The glandular stomach toxicity of trans-4-Acetylaminostilbene (trans-AAS) is not caused by tissue-specific metabolic activation.
- The parent compound's accumulation in the glandular stomach is the likely cause of toxicity.
- Stomach impairment and high parent compound concentrations are key factors in trans-AAS poisoning.
Related Concept Videos
Physical Properties of Amines
Mutagenicity and Carcinogenicity
Bioactivation and Tissue Toxicity
Toxicity Testing in Animals

